InvestSMART

Microba Life Sciences Limited (ASX: MAP) - Announcements

Current share price for MAP : $0.035 0.001 (1.43%)+

ASX company news and announcements for Microba Life Sciences Limited (MAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Microba Life Sciences Limited (MAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Microba Life Sciences Limited (MAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Microba Life Sciences Limited (MAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$26 Letter to Shareholders, Notice of EGM & Proxy Form 8 Jul 2025 4:04PM $0.088 $0.035 fallen by 60.80%
$26 Ceasing to be a substantial holder 2 Jul 2025 3:56PM $0.085 $0.035 fallen by 59.41%
$26 Cleansing Notice 27 Jun 2025 11:38AM $0.084 $0.035 fallen by 58.93%
$26 Letter to SPP Eligible Shareholders 27 Jun 2025 11:37AM $0.084 $0.035 fallen by 58.93%
$26 Disclosure Document - Prospectus 27 Jun 2025 11:37AM $0.084 $0.035 fallen by 58.93%
$26 Application for quotation of securities - MAP 27 Jun 2025 9:51AM $0.084 $0.035 fallen by 58.93%
$26 Reinstatement to Quotation 23 Jun 2025 12:35PM $0.115 $0.035 fallen by 70%
$26 Proposed issue of securities - MAP 23 Jun 2025 12:35PM $0.115 $0.035 fallen by 70%
$26 Proposed issue of securities - MAP 23 Jun 2025 12:35PM $0.115 $0.035 fallen by 70%
$26 Proposed issue of securities - MAP 23 Jun 2025 12:35PM $0.115 $0.035 fallen by 70%
$26 Proposed issue of securities - MAP 23 Jun 2025 12:35PM $0.115 $0.035 fallen by 70%
$26 Strategic Investment & Equity Raise Presentation 23 Jun 2025 12:35PM $0.115 $0.035 fallen by 70%
$26 Microba secures $14.5 million to drive clinical adoption 23 Jun 2025 12:35PM $0.115 $0.035 fallen by 70%
$26 Suspension from Quotation 23 Jun 2025 10:56AM $0.115 $0.035 fallen by 70%
$26 Trading Halt 19 Jun 2025 9:28AM $0.115 $0.035 fallen by 70%
$26 MetaPanel Pathogen Study Delivers Breakthrough Results 21 May 2025 9:12AM $0.160 $0.035 fallen by 78.44%
$26 Landmark GI Study Results from over 4,600 patients 14 May 2025 9:02AM $0.175 $0.035 fallen by 80.29%
$26 Notification of cessation of securities - MAP 12 May 2025 5:08PM $0.175 $0.035 fallen by 80.29%
$26 Q3 FY25 Quarterly Investor Presentation & Webinar 30 Apr 2025 9:23AM $0.225 $0.035 fallen by 84.67%
$26 Q3 FY25 Quarterly Activities Report & Appendix 4C 30 Apr 2025 9:22AM $0.225 $0.035 fallen by 84.67%
$26 Details of Q3 FY25 Quarterly Report, Appendix 4C & Webinar 28 Apr 2025 2:33PM $0.190 $0.035 fallen by 81.84%
$26 HealthInvest 2025 Investor Conference Presentation 2 Apr 2025 9:15AM $0.200 $0.035 fallen by 82.75%
$26 Webinar Presentation - Diagnostics Deep Dive - Part A 20 Mar 2025 9:06AM $0.190 $0.035 fallen by 81.84%
$26 Diagnostics Growth & Metrics Webinar - Part B 20 Mar 2025 9:06AM $0.190 $0.035 fallen by 81.84%
$26 Investor Webinar & Newsletter 4 Mar 2025 9:37AM $0.200 $0.035 fallen by 82.75%

101 - 125 of 714 results

Page 5 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.